Drug Trials Snapshots: JOENJA
Summary
JOENJA is a kinase inhibitor that is used to treat activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adult and pediatric patients 12 years o...
Description
JOENJA is a kinase inhibitor that is used to treat activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adult and pediatric patients 12 years o...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source